Notable candidates in Phase II/III trials include arhalofenate (MBX102), AC201, the RDEA group (including lesinurad), tranilast, and ulodesine (BCX4208)
As a modified peptide analog rather than a full receptor-active growth hormone construct, AOD 9604 is distinguished by its selective interaction with metabolic signaling pathways associated with lipid mobilization rather than canonical GH receptor activation
Intensified enforcement at the borders during two-week Operation 4 In addition to the online listings that were removed, HSA seized 6,641 units of illegal health products at the borders, with the majority (88%) intercepted via postal services
In recent years, growing interest has emerged regarding the potential role of vitamin, mineral, and nutrient supplementation in PCOS management
B12 deficiency is present in close to 50% of people over 60 years of age
GHK-Cu is a complex consisting of the tripeptide GHK (glycyl-histidyl-lysine) and copper (Cu).2 GHK was discovered in 1973 by Dr